These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 36070939)

  • 41. Pathological and regulatory effects of anti-myelin antibodies in experimental allergic encephalomyelitis in mice.
    Morris-Downes MM; Smith PA; Rundle JL; Piddlesden SJ; Baker D; Pham-Dinh D; Heijmans N; Amor S
    J Neuroimmunol; 2002 Apr; 125(1-2):114-24. PubMed ID: 11960647
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Myelin Oligodendrocyte Glycoprotein as an Autoantigen in Inflammatory Demyelinating Diseases of the Central Nervous System.
    Eliseeva DD; Zakharova MN
    Biochemistry (Mosc); 2023 Apr; 88(4):551-563. PubMed ID: 37080940
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease: Presentation, Diagnosis, and Management.
    Hur MH
    Pediatr Ann; 2021 Jun; 50(6):e254-e258. PubMed ID: 34115560
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Brain histopathological study and prognosis in MOG antibody-associated demyelinating pseudotumor.
    Shu Y; Long Y; Wang S; Hu W; Zhou J; Xu H; Chen C; Ou Y; Lu Z; Lau AY; Yu X; Kermode AG; Qiu W
    Ann Clin Transl Neurol; 2019 Feb; 6(2):392-396. PubMed ID: 30847372
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Clinical and neuroradiological differences of paediatric acute disseminating encephalomyelitis with and without antibodies to the myelin oligodendrocyte glycoprotein.
    Baumann M; Sahin K; Lechner C; Hennes EM; Schanda K; Mader S; Karenfort M; Selch C; Häusler M; Eisenkölbl A; Salandin M; Gruber-Sedlmayr U; Blaschek A; Kraus V; Leiz S; Finsterwalder J; Gotwald T; Kuchukhidze G; Berger T; Reindl M; Rostásy K
    J Neurol Neurosurg Psychiatry; 2015 Mar; 86(3):265-72. PubMed ID: 25121570
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
    Lee DH; Linker RA
    Expert Opin Ther Targets; 2012 May; 16(5):451-62. PubMed ID: 22494461
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pathogenic myelin oligodendrocyte glycoprotein antibodies recognize glycosylated epitopes and perturb oligodendrocyte physiology.
    Marta CB; Oliver AR; Sweet RA; Pfeiffer SE; Ruddle NH
    Proc Natl Acad Sci U S A; 2005 Sep; 102(39):13992-7. PubMed ID: 16172404
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The spectrum of MOG autoantibody-associated demyelinating diseases.
    Reindl M; Di Pauli F; Rostásy K; Berger T
    Nat Rev Neurol; 2013 Aug; 9(8):455-61. PubMed ID: 23797245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical spectrum of inflammatory central nervous system demyelinating disorders associated with antibodies against myelin oligodendrocyte glycoprotein.
    Akaishi T; Sato DK; Takahashi T; Nakashima I
    Neurochem Int; 2019 Nov; 130():104319. PubMed ID: 30365980
    [TBL] [Abstract][Full Text] [Related]  

  • 50. First Clinical Experience with Anti-myelin Oligodendrocyte Glycoprotein Antibody-Positive Optic Neuritis.
    Heckmann J; Todorova M; Müller S; Broser PJ; Sturm V
    Klin Monbl Augenheilkd; 2020 Apr; 237(4):458-463. PubMed ID: 32092775
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Anti-myelin oligodendrocyte glycoprotein (MOG) antibodies in a Japanese boy with recurrent optic neuritis.
    Tsuburaya RS; Miki N; Tanaka K; Kageyama T; Irahara K; Mukaida S; Shiraishi K; Tanaka M
    Brain Dev; 2015 Jan; 37(1):145-8. PubMed ID: 24582475
    [TBL] [Abstract][Full Text] [Related]  

  • 52. SARS-CoV-2-related Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease: A Case Report and Literature Review.
    Ide T; Kawanami T; Eriguchi M; Hara H
    Intern Med; 2022 Apr; 61(8):1253-1258. PubMed ID: 35135920
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study.
    Mariotto S; Ferrari S; Monaco S; Benedetti MD; Schanda K; Alberti D; Farinazzo A; Capra R; Mancinelli C; De Rossi N; Bombardi R; Zuliani L; Zoccarato M; Tanel R; Bonora A; Turatti M; Calabrese M; Polo A; Pavone A; Grazian L; Sechi G; Sechi E; Urso D; Delogu R; Janes F; Deotto L; Cadaldini M; Bianchi MR; Cantalupo G; Reindl M; Gajofatto A
    J Neurol; 2017 Dec; 264(12):2420-2430. PubMed ID: 29063242
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease.
    Hacohen Y; Wong YY; Lechner C; Jurynczyk M; Wright S; Konuskan B; Kalser J; Poulat AL; Maurey H; Ganelin-Cohen E; Wassmer E; Hemingway C; Forsyth R; Hennes EM; Leite MI; Ciccarelli O; Anlar B; Hintzen R; Marignier R; Palace J; Baumann M; Rostásy K; Neuteboom R; Deiva K; Lim M
    JAMA Neurol; 2018 Apr; 75(4):478-487. PubMed ID: 29305608
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The pathology of central nervous system inflammatory demyelinating disease accompanying myelin oligodendrocyte glycoprotein autoantibody.
    Höftberger R; Guo Y; Flanagan EP; Lopez-Chiriboga AS; Endmayr V; Hochmeister S; Joldic D; Pittock SJ; Tillema JM; Gorman M; Lassmann H; Lucchinetti CF
    Acta Neuropathol; 2020 May; 139(5):875-892. PubMed ID: 32048003
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Myelin oligodendrocyte glycoprotein antibodies in genetic leukodystrophies.
    Eroglu-Ertugrul NG; Yousefi M; Pekgül F; Doran T; Günbey C; Topcu M; Oguz KK; Ozkara HA; Vural A; Anlar B
    J Neuroimmunol; 2022 Aug; 369():577916. PubMed ID: 35752102
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Paediatric acute disseminated encephalomyelitis followed by optic neuritis: disease course, treatment response and outcome.
    Wong YYM; Hacohen Y; Armangue T; Wassmer E; Verhelst H; Hemingway C; van Pelt ED; Catsman-Berrevoets CE; Hintzen RQ; Deiva K; Lim MJ; Rostásy K; Neuteboom RF
    Eur J Neurol; 2018 May; 25(5):782-786. PubMed ID: 29443442
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Isolated seizures during the first episode of relapsing myelin oligodendrocyte glycoprotein antibody-associated demyelination in children.
    Ramanathan S; O'grady GL; Malone S; Spooner CG; Brown DA; Gill D; Brilot F; Dale RC
    Dev Med Child Neurol; 2019 May; 61(5):610-614. PubMed ID: 30221764
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Incidence of pediatric neuromyelitis optica spectrum disorder and myelin oligodendrocyte glycoprotein antibody-associated disease in Denmark 2008‒2018: A nationwide, population-based cohort study.
    Boesen MS; Jensen PEH; Born AP; Magyari M; Nilsson AC; Hoei-Hansen C; Blinkenberg M; Sellebjerg F
    Mult Scler Relat Disord; 2019 Aug; 33():162-167. PubMed ID: 31276927
    [TBL] [Abstract][Full Text] [Related]  

  • 60. An Adult Case of Anti-Myelin Oligodendrocyte Glycoprotein (MOG) Antibody-associated Multiphasic Acute Disseminated Encephalomyelitis at 33-year Intervals.
    Numa S; Kasai T; Kondo T; Kushimura Y; Kimura A; Takahashi H; Morita K; Tanaka A; Noto Y; Ohara T; Nakagawa M; Mizuno T
    Intern Med; 2016; 55(6):699-702. PubMed ID: 26984094
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.